Breaking newsCOVID-19Research
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
The European Parliament marked Brain Health Day: Prevention, Policy, Progress with a high‑level programme hosted by MEP Angelika Winzig, bringing renewed political attention to Europe’s urgent need for an integrated brain health strategy.
Latest Posts
-
-
The antigenic anatomy of SARS-CoV-2 receptor binding domain
-
Breaking newsCOVID-19Research
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera -
Breaking newsCOVID-19Research
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape
Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape -
Assessing the influence of climate on wintertime SARS-CoV-2 outbreaks
-
Breaking newsCOVID-19Research
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants -
Reduction in mobility and COVID-19 transmission
-
Breaking newsCOVID-19ResearchGlobal absence and targeting of protective immune states in severe COVID-19
Global absence and targeting of protective immune states in severe COVID-19 -
Breaking newsCOVID-19Research
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study
Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study -
Breaking newsCOVID-19ResearchEffect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial
Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial -
Breaking newsCOVID-19ResearchEffect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: A randomized clinical trial
Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: A randomized clinical trial -
Alzheimer Europe continues to develop and improve its Clinical Trials Watch (CTW), an innovative online resource providing up-to-date accessible information on clinical trials currently recruiting participants in a least one European country. -
Scientific CornerThe Future of Brain Research: EU-Initiatives and Experts Together for a Shared European Brain Research Agenda
In late 2019, the European Brain Council (EBC) launched the development of the Shared European Brain Research Agenda (SEBRA). -
Paper of the MonthEAN NewsCOVID-19COVID-19 Paper of the month: A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis
For March 2021, we have selected: Krienke C. et al., A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis. Science 2021; 371: 145-153. doi: 10.1126/science.aay3638. -
Clinical Fellowship Reports 2020